Replies to post #197654 on Enzolytics Inc (ENZC)

[sspalmo]

How does the SAGA deal only include VIRO and not BGEN? If the deal was not legally completed (I don't believe it was) why is it that only the VIRO assets of the business combination agreement would be returned to ENZC? Why are the BGEN assets allowed to break free after a failed SPAC business combination agreement and not be returned to ENZC? How is the SPAC allowed to miss an extension deadline and then skip follow-up extension filings (and payments), but then be allowed to pretend they completed their business combination agreement? There were other filings and requirements they were delinquent on as well. Isn't this against their articles of inception? Does contract law matter at all?

[I-Glow]

BGEN doesn't own any assets - if so post the patents.

From BioClonetics Immunotherapeutics

INTELLECTUAL PROPERTY

The Company protects its technology through an aggressive strategy to cover its intellectual property. Such intellectual property includes:

PROPRIETARY CELL LINE PRODUCING CLONE 3
- The Company’s Clone 3 cell line, that produces fully human monoclonal
antibodies (mAbs) that specifically target and neutralize the HIV-1 virus, is
proprietary to the Company.

INTELLECTUAL PROPERTY PORTFOLIO
- Pending patent coverage on the recombinant of the Clone 3 antibody. This form of the Clone 3 antibody is prepared using the known amino acid sequence of the Antibody in conjunction with a high producing CHO cell line for generating recombinant
material that would ultimately be used in patient application.

- Pendintg Patent coverage of small molecules (mini-peptides) for commercial use derived from the structure of the Clone 3 antibody for interrupting and preventing binding between the HIV virus and the human CD4+ cell.
- Coverage is directed to blocking peptides that bind to and neutralize the HIV virus, and
- Competitive peptides that bind to the target CD4+ cells at the point of virus access into the human cell to prevent infection.

When you file a provisional patent - which excludes any prior art - it is a 12 month placeholder and you are allowed to use the term patent pending.

Here is an example:

Patent number: 6083504
InventorJoseph P. Cotropia
Assignee BIOCLONETICS IMMUNOTHERAPEUTICS Inc

Status: Expired

Then we have Patent Number 5777074

InventorJoseph P. Cotropia
Assignee BIOCLONETICS IMMUNOTHERAPEUTICS Inc

Status: Expired

US6008044A - and it has expired.

BIOCLONETICS Immunotherapeutics is a empty shell without any IP.

IG